Skip to main content
. Author manuscript; available in PMC: 2022 Jun 14.
Published in final edited form as: J Alzheimers Dis. 2021;84(3):1079–1089. doi: 10.3233/JAD-210701

Figure 2. Autophagy pathway evaluation following VPS35 silencing.

Figure 2.

A) Representative Western blots for ATGs proteins, LC3B and SQSTM1/p62 in N2A-APPswe cells transfected with VPS35 siRNA or controls (Lipofectamine, scramble siRNA). B) Densitometric analyses of the immunoreactivity to the antibodies shown in panel A (* p< 0.05 vs Lipofectamine; ** p< 0.001 vs Lipofectamine; *** p< 0.001 vs Lipofectamine) C) All results are mean ± SEM (N=2 per groups, three individual experiments).